Live Breaking News & Updates on Assembly Biosciences Stock

Stay updated with breaking news from Assembly biosciences stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Assembly Biosciences, Inc. (NASDAQ:ASMB) CEO Jason A. Okazaki Sells 1,569 Shares

Assembly Biosciences, Inc. (NASDAQ:ASMB) CEO Jason A. Okazaki Sells 1,569 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Jasona Okazaki , Acuitas Investments , News Ratings For Assembly Biosciences Daily , Assembly Biosciences , Securities Exchange Commission , Quarter For Assembly Biosciences , Assembly Biosciences Stock , Hedge Funds Weigh In On Assembly Biosciences , Assembly Biosciences Inc , Assembly Biosciences Company Profile , Get Free Report , Exchange Commission , Free Report , Assembly Biosciences Daily ,

Assembly Biosciences (NASDAQ:ASMB) Upgraded by StockNews.com to Hold

StockNews.com upgraded shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) from a sell rating to a hold rating in a research note published on Friday. Separately, HC Wainwright reaffirmed a neutral rating on shares of Assembly Biosciences in a research report on Monday, April 1st. Check Out Our Latest Stock Report on Assembly Biosciences Assembly […] ....

United States , Alexander Schornstein , News Ratings For Assembly Biosciences Daily , Tower Research Capital , Jpmorgan Chase Co , Hedge Funds Weigh In On Assembly Biosciences , Securities Exchange Commission , Assembly Biosciences Company Profile , Assembly Biosciences , Assembly Biosciences Inc , Assembly Biosciences Stock , Free Report , Exchange Commission , Street Group , Research Capital , Two Sigma Investments , Get Free Report , Assembly Biosciences Daily , Nasdaq Asmb , Stocknews Com ,

Assembly Biosciences' (ASMB) Neutral Rating Reiterated at HC Wainwright

HC Wainwright reissued their neutral rating on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a research note issued to investors on Monday, Benzinga reports. HC Wainwright also issued estimates for Assembly Biosciences’ Q1 2024 earnings at ($2.74) EPS, Q2 2024 earnings at ($2.96) EPS, Q3 2024 earnings at ($3.29) EPS, Q4 2024 earnings […] ....

United States , Alexander Schornstein , Assembly Bioscience , Insider Activity At Assembly Biosciences , Acuitas Investments , Marquette Asset Management , Hedge Funds Weigh In On Assembly Biosciences , Vanguard Group Inc , Assembly Biosciences Company Profile , Assembly Biosciences Inc , Geode Capital Management , Assembly Biosciences Stock , Northern Trust Corp , Securities Exchange Commission , Assembly Biosciences , News Ratings For Assembly Biosciences Daily , Free Report , Exchange Commission , Trust Corp , Asset Management , Capital Management , Get Free Report , Assembly Biosciences Daily , Nasdaq Asmb , Reiterated Rating , Hc Wainwright ,